Related Experiment Video
Updated: May 13, 2026

09:58
Syringe-injectable Mesh Electronics for Stable Chronic Rodent Electrophysiology
Published on: July 21, 2018
Single glucose biofuel cells implanted in rats power electronic devices
A Zebda1, S Cosnier, J-P Alcaraz
1Univ Grenoble 1, CNRS, Département de Chimie Moleculaire, UMR-5250, ICMG FR-2607, BP-53, 38041 Grenoble Cedex 9, France.
Scientific Reports
|March 23, 2013
Summary
Researchers developed the first implantable glucose biofuel cell (GBFC) powered by body fluids. This innovative device successfully powered electronic devices in rats with no adverse reactions after 110 days.
Area of Science:
- Biomedical Engineering
- Electrochemistry
- Materials Science
Background:
- Implantable electronic devices require reliable, long-term power sources.
- Existing power sources often face limitations such as finite lifespan or need for external recharging.
- Biofuel cells offer a promising alternative by converting biological fuels into electrical energy.
Purpose of the Study:
- To develop and evaluate the first implantable glucose biofuel cell (GBFC) capable of powering electronic devices using mammalian body fluids.
- To assess the power generation capabilities and biocompatibility of the novel GBFC in a living organism.
Main Methods:
- Fabrication of a GBFC utilizing carbon nanotube/enzyme electrodes with glucose oxidase and laccase.
- Implantation of the GBFC into the abdominal cavity of a rat.
- Measurement of open-circuit voltage, power output, power density, and volumetric power.
- Testing the ability of the GBFC to power a light-emitting diode (LED) and a digital thermometer.
- Monitoring the implantation site for signs of rejection or inflammation over 110 days.
Main Results:
- The implanted GBFC generated an average open-circuit voltage of 0.57 V.
- A power output of 38.7 μW was achieved, with a power density of 193.5 μW cm⁻² and volumetric power of 161 μW mL⁻¹.
- A single GBFC successfully powered an LED and a digital thermometer.
- No signs of rejection or inflammation were observed after 110 days of implantation.
Conclusions:
- The developed implantable glucose biofuel cell is the first to generate sufficient power from body fluids to operate electronic devices.
- The GBFC demonstrates excellent biocompatibility and sustained power output in vivo.
- This technology holds significant potential for self-powered implantable medical devices and biosensors.
